OMIM Search - '+cs_neurologic:("mental retardation" OR "cognitive impairment" OR "intellectual impairment" OR "impaired intellectual development" OR "intellectual disability" OR "mentally retarded" OR "cognitive delay" OR "Delayed intellectual development" OR "Delayed cognitive development" OR "Cognitive deficits" OR "Mental deficiency" OR "intellectual decline" OR "Cognitive dysfunction" OR "Cognitive decline" OR "Cognitive function loss" OR "Cognitive defects" OR "Cognitive deterioration" OR "Cognitive regression" OR "Cognitive disability" OR "Cognitive development may be significantly impaired or normal" OR "Impaired cognitive development" OR "No cognitive development" OR "Intellectual developmental impairment" OR "Intellectual deterioration" OR "Intellectual delay" OR "Impaired or absent intellectual development" OR "Intellectual developmental deficit" OR "Mental deterioration" OR "Mental lethargy" OR "Mental impairment" OR "Mental delay or retardation" OR "Retarded mental development" OR "Progressive mental and motor deterioration" OR "Mental and motor retardation") (Search in: Prefixes: #, Chromosomes: 16, 17, 18, 19, 20, 21, 22, X, Y)'
Downloaded:	Nov 17, 2020
Copyright (c) 1966-2020 Johns Hopkins University OMIM, data are provided for research purposes only.

MIM Number	Title	Included Titles	Cytogenetic Location	Genomic Coordinates (From NCBI/GRCh38)	Entrez Gene ID
#613752	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY		20q11.22		
#618186	NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3		17q21.2		
#604168	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN		18q23		
#615157	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2		17p12		
#617672	NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA		17q21.31		
#160900	MYOTONIC DYSTROPHY 1; DM1		19q13.32		
#103580	PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A		20q13.32		
#612462	PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C		20q13.32		
#612463	PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP		20q13.32		
#300257	DANON DISEASE		Xq24		
#616230	EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8		19p13.11		
#245570	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD	LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED	16p13.2		
#613675	CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB		17q11.2	17:27400000-33500000	
#301008	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG		Xp22.12		
#619051	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7		19q13.12		
#258501	3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3		19q13.32		
#266920	SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9		16p13.3		
#606159	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3		19q13.33		
#607259	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7		16q24.3		
#300100	ADRENOLEUKODYSTROPHY; ALD	ADRENOMYELONEUROPATHY, INCLUDED; AMN, INCLUDED	Xq28		
#182410	SNEDDON SYNDROME; SNDNS		22q11.1		
#219080	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1		20q13.32		
#603218	HUNTINGTON DISEASE-LIKE 1; HDL1		20p13		
#234200	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1		20p13		
#267750	KNOBLOCH SYNDROME 1; KNO1		21q22.3		
#300623	FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS		Xq27.3		
#605361	SPINOCEREBELLAR ATAXIA 14; SCA14		19q13.42		
#612199	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1; CRMCC1		17p13.1		
#612319	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35		16q23.1		
#612953	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14		22q13.1		
#610217	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	KARAK SYNDROME, INCLUDED	22q13.1		
#610245	SPINOCEREBELLAR ATAXIA 23; SCA23		20p13		
#610489	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1		17q24.2		
#614298	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4		19q12		
#614561	LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC		17p13.1		
#614706	CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11		17q21.31		
#615530	PARKINSON DISEASE 20, EARLY-ONSET; PARK20		21q22.11		
#615643	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6		17q21.2		
#618824	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE; IBGC8		21q21.3		
#618093	SPINOCEREBELLAR ATAXIA 48; SCA48		16p13.3		
#618213	INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE		19q13.2		
#229100	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY		21q22.3		
#618598	SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE; STAHP		21q22.11		
#300114	RAYNAUD-CLAES SYNDROME; MRXSRC		Xp22.2		
#300882	CORNELIA DE LANGE SYNDROME 5; CDLS5		Xq13.1		
#300957	MENTAL RETARDATION, X-LINKED 12; MRX12		Xq25		
#211380	ELSAHY-WATERS SYNDROME; ESWS		16q21		
#605275	NOONAN SYNDROME 2; NS2		22q11.21		
#300261	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, ARMFIELD TYPE; MRXSA		Xq28	X:148000000-156040895	
#300423	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH		Xp11.4		
#300978	TONNE-KALSCHEUER SYNDROME; TOKAS		Xq13.2		
#301022	MULLEGAMA-KLEIN-MARTINEZ SYNDROME; MKMS		Xq25		
#301024	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108		Xp11.3		
#301025	PAGANINI-MIOZZO SYNDROME; MRXSPM		Xq26.2		
#301029	SHUKLA-VERNON SYNDROME; SHUVER		Xq26.1		
#301031	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc; CDG1CC		Xq21.1		
#301032	BASILICATA-AKHTAR SYNDROME; MRXSBA		Xp22.2		
#301039	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE; MRXSHD		Xq24		
#301041	WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED; WRWFFR		Xq11.2		
#301043	HOLOPROSENCEPHALY 13, X-LINKED; HPE13		Xq25		
#314580	WIEACKER-WOLFF SYNDROME; WRWF		Xq11.2		
#613076	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT AND DEVELOPMENTAL DELAY; MPMCD		16p13.3		
#614559	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD		22q13.2		
#617162	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46; DEE46		19q13.33		
#618009	INTELLECTUAL DEVELOPMENTAL DISORDER 61; MRD61		17q23.2		
#618124	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID		21q22.3		
#618165	BONE MARROW FAILURE SYNDROME 5; BMFS5		17p13.1		
#618176	NEPHROTIC SYNDROME, TYPE 17; NPHS17		17q25.1		
#618197	MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23		22q11.21		
#618238	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16		20p12.1		
#618249	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28		19p13.11		
#618273	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM		19p13.13		
#618282	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3		20q11.22		
#618302	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68		19p13.13		
#618316	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF		17q25.1		
#618324	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2		16q22.1		
#618347	GALLOWAY-MOWAT SYNDROME 6; GAMOS6		21q22.3		
#618360	BRAIN SMALL VESSEL DISEASE 3; BSVD3		19p13.11		
#618374	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72		17q12		
#618416	METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN		19p13.11		
#618430	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA		22q13.2		
#618443	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA		16p13.3		
#618505	NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA		17p13.1		
#618577	NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF		17q25.3		
#618590	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS; NEDBSS		20q11.22		
#618603	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES; NEDHIB		17p13.1		
#618635	SIDDIQI SYNDROME; SIDDIS		20q13.12		
#618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF		19q13.42		
#618677	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10; CDCBM10		19p13.3		
#618721	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82; DEE82		16q21		
#618760	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS; NEDHAHM		17p13.1		
#618770	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE; SPG82		17q25.3		
#618774	CEBALID SYNDROME; CEBALID		22q12.1		
#618793	INTELLECTUAL DEVELOPMENTAL DISORDER 62; MRD62		17p13.1		
#618828	NABAIS SA-DE VRIES SYNDROME, TYPE 1; NSDVS1		17q21.33		
#618829	NABAIS SA-DE VRIES SYNDROME, TYPE 2; NSDVS2		17q21.33		
#618859	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISTIC FEATURES AND/OR STRUCTURAL BRAIN ABNORMALITIES; NEDASB		19q13.32		
#618862	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES; NEDHYMS		21q22.3		
#618876	EPILEPSY, PROGRESSIVE MYOCLONIC, 11; EPM11		19p13.3		
#618906	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY, WITH OR WITHOUT SEIZURES; IDDALDS		17q23.2-q23.3		
#618974	LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME; LIGOWS		16p11.2		
#619033	VISSERS-BODMER SYNDROME; VIBOS		16q21		
#619052	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8; MC4DN8		17q23.3		
#619055	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12		19p13.2		
#619056	NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND DYSMORPHIC FACIES; NEDSID		16p11.2		
#619058	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 14; MC4DN14		17q21.2		
#619060	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16		16q24.1		
#619063	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19		20p11.23		
#215470	BOUCHER-NEUHAUSER SYNDROME; BNHS		19p13.2		
#603516	SPINOCEREBELLAR ATAXIA 10; SCA10		22q13.31		
#252011	MITOCHONDRIAL COMPLEX II DEFICIENCY		5p15.33, 11q23.1, 19q13.12		
#300232	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY; SEMDHL		Xq26.1		
#300555	DENT DISEASE 2		Xq26.1		
#300590	CORNELIA DE LANGE SYNDROME 2; CDLS2		Xp11.22		
#300842	MCLEOD SYNDROME; MCLDS	MCLEOD SYNDROME WITH CHRONIC GRANULOMATOUS DISEASE, INCLUDED	Xp21.1		
#301045	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr; CDG2R		Xp11.4		
#310490	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 4, WITH OR WITHOUT CEREBELLAR ATAXIA; CMTX4		Xq26.1		
#607485	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	APHASIA, PRIMARY PROGRESSIVE, INCLUDED; PPA, INCLUDED	17q21.31		
#608627	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8		20q13.32		
#614018	EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6		17q21.32		
#614487	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5		18p11.21		
#614807	MYOPATHY, CENTRONUCLEAR, 4; CNM4		16p13.3		
#615160	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5		16p12.2		
#615483	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5		22q13.1		
#615768	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16		16p13.3		
#615942	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44; MRT44		17q25.1		
#616212	LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6		16q21		
#616267	ATAXIA-OCULOMOTOR APRAXIA 4; AOA4		19q13.33		
#616680	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE; SPG75		19q13.12		
#617284	DYSTONIA 28, CHILDHOOD-ONSET; DYT28		19q13.12		
#617629	SCHIZOPHRENIA 19; SCZD19		20q11.22		
#245300	KURU, SUSCEPTIBILITY TO		20p13		
#250100	METACHROMATIC LEUKODYSTROPHY; MLD	PSEUDOARYLSULFATASE A DEFICIENCY, INCLUDED	22q13.33		
#254800	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG		21q22.3		
#257220	NIEMANN-PICK DISEASE, TYPE C1; NPC1	NIEMANN-PICK DISEASE, TYPE D, INCLUDED	18q11.2		
#278730	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD		19q13.32		
#304700	MOHR-TRANEBJAERG SYNDROME; MTS		Xq22.1		
#607151	MOYAMOYA DISEASE 2; MYMY2		17q25.3		
#136140	FLOATING-HARBOR SYNDROME; FLHS		16p11.2		
#269500	SCLEROSTEOSIS 1; SOST1		17q21.31		
#609242	KANZAKI DISEASE		22q13.2		
#618205	SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS		17p13.1		
#114300	ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3		18p11.22-p11.21		
#300148	MEHMO SYNDROME; MEHMO		Xp22.11		
#157600	MIRROR MOVEMENTS 1; MRMV1		18q21.2		
#604364	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1; FFEVF1		22q12.2-q12.3		
#605021	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME		16p13.3		
#242150	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KIDAR		22q12.2		
#275400	OLIVER-MCFARLANE SYNDROME; OMCS		19p13.2		
#300434	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX		Xp11.22		
#300438	HSD10 MITOCHONDRIAL DISEASE; HSD10MD		Xp11.22		
#300615	BRUNNER SYNDROME; BRNRS	ANTISOCIAL BEHAVIOR, SUSCEPTIBILITY TO, INCLUDED	Xp11.3		
#300830	AUTISM, SUSCEPTIBILITY TO, X-LINKED 4; AUTSX4		Xp22.11		
#300872	AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6		Xq28		
#300884	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36; DEE36	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Is, INCLUDED; CDG1S, INCLUDED	Xq23		
#300934	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y		Xq28		
#300958	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE; MRXSSB		Xp11.4		
#300960	MEND SYNDROME; MEND		Xp11.23		
#300966	MENTAL RETARDATION, X-LINKED, SYNDROMIC 33; MRXS33		Xq13.1		
#300967	MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34		Xq13.1		
#300968	MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED; MRXS99F		Xp11.4		
#300972	IMMUNODEFICIENCY 47; IMD47		Xq28		
#300979	Xq25 DUPLICATION SYNDROME	Xq25 TRIPLICATION SYNDROME, INCLUDED	Xq25	X:121800000-129500000	
#300982	MENTAL RETARDATION, X-LINKED 103; MRX103		Xp22.11		
#300983	MENTAL RETARDATION, X-LINKED 104; MRX104		Xp22.2		
#300984	MENTAL RETARDATION, X-LINKED 105; MRX105		Xp11.23		
#300986	MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB		Xq22.1		
#300997	MENTAL RETARDATION, X-LINKED 106; MRX106		Xq13.1		
#300998	MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35		Xq28		
#301006	GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2		Xq28		
#301013	MENTAL RETARDATION, X-LINKED 107; MRX107		Xq24		
#301026	KEIPERT SYNDROME; KPTS		Xq26.2		
#301030	VAN ESCH-O'DRISCOLL SYNDROME; VEODS		Xp22.1-p21.3		
#301220	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR		Xp22.1-p21.3		
#309530	MENTAL RETARDATION, X-LINKED 1; MRX1		Xp11.22		
#614080	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1		18q21.33		
#614583	BARAITSER-WINTER SYNDROME 2; BRWS2		17q25.3		
#614820	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2		19q13.2		
#615244	NEPHROTIC SYNDROME, TYPE 8; NPHS8		17q25.3		
#615398	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3		20q13.12		
#615485	BAINBRIDGE-ROPERS SYNDROME; BRPS		18q12.1		
#615560	OTOFACIOCERVICAL SYNDROME 2; OTFCS2		20p11.22		
#615873	HELSMOORTEL-VAN DER AA SYNDROME; HVDAS		20q13.13		
#615979	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45		16q24.2		
#615996	BARDET-BIEDL SYNDROME 19; BBS19		22q12.3		
#616025	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11		17q12		
#616260	TENORIO SYNDROME; TNORS		18q12.1		
#616263	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD		17q23.1		
#616281	NEURODEVELOPMENTAL DISORDER WITH SPASTIC PARAPLEGIA AND MICROCEPHALY; NEDSPM		16q11.2		
#616393	MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38		20q13.33		
#616645	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34; DEE34		20q13.12		
#616652	YUAN-HAREL-LUPSKI SYNDROME; YUHAL		17p12-p11.2	17:10800000-22700000	
#616863	HAO-FOUNTAIN SYNDROME; HAFOUS	CHROMOSOME 16p13.2 DELETION SYNDROME, INCLUDED	16p13.2		
#616901	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR; DEDSSH		17p13.3		
#616938	COFFIN-SIRIS SYNDROME 5; CSS5		17q21.2		
#617062	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS		20p13		
#617106	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42; DEE42		19p13.13		
#617120	JOUBERT SYNDROME 27; JBTS27		17p11.2		
#617121	JOUBERT SYNDROME 28; JBTS28		17q22		
#617140	ZTTK SYNDROME; ZTTKS		21q22.11		
#617157	SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES; SBIDDS		16q22.1		
#617169	SOTOS SYNDROME 3; SOTOS3		19p13.3		
#617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57		19q13.42		
#617193	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT		17q25.3		
#617201	PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7		18q21.31		
#617219	CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL		19q13.11	19:31900000-35100000	
#617270	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58		18q12.2		
#617393	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM		19p13.13		
#617404	MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY; MDCCAID		17p13.3		
#617450	JANSEN-DE VRIES SYNDROME; JDVS		17q23.2		
#617493	NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM		16q13		
#617516	STANKIEWICZ-ISIDOR SYNDROME; STISS		17q24.2		
#617542	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2		18q21.2		
#617562	MECKEL SYNDROME 13; MKS13	JOUBERT SYNDROME 29, INCLUDED; JBTS29, INCLUDED	17p13.1		
#617563	OROFACIODIGITAL SYNDROME XVI; OFD16		17p13.1		
#617599	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55; DEE55		21q22.13		
#617600	MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45		19q13.2		
#617604	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA		21q22.11		
#617694	AL KAISSI SYNDROME; ALKAS		16q24.3		
#617698	3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9		19q13.2		
#617755	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL		17q24.2		
#617854	MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56		17q23.1		
#617883	FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS		17q21.31		
#617977	NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS		17q25.3		
#618050	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57		17q23.2		
#618087	SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND		17q21.33		
#618332	MENKE-HENNEKAM SYNDROME 1; MKHK1		16p13.3		
#618333	MENKE-HENNEKAM SYNDROME 2; MKHK2		22q13.2		
#618371	TURNPENNY-FRY SYNDROME; TPFS		17q12		
#618786	IMAGAWA-MATSUMOTO SYNDROME; IMMAS		17q11.2		
#618840	ALOPECIA-MENTAL RETARDATION SYNDROME 4; APMR4		21q22.3		
#618889	LIBERFARB SYNDROME; LIBF		22q12.2		
#618929	AGENESIS OF CORPUS CALLOSUM, CARDIAC, OCULAR, AND GENITAL SYNDROME; ACOGS		18q12.1		
#618977	OPTIC ATROPHY 12; OPA12		18p11.21		
#237310	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD		17q21.31		
#602541	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC		22q13.33		
#242860	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1		20q11.21		
#300486	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE		Xq12		
#300558	MENTAL RETARDATION, X-LINKED 30; MRX30		Xq23		
#310200	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD		Xp21.2-p21.1		
#101800	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1		17q24.2		
#103050	ADENYLOSUCCINASE DEFICIENCY; ADSLD		22q13.1		
#105650	DIAMOND-BLACKFAN ANEMIA 1; DBA1		19q13.2		
#107480	TOWNES-BROCKS SYNDROME 1; TBS1	TOWNES-BROCKS-BRANCHIOOTORENAL-LIKE SYNDROME, INCLUDED	16q12.1		
#115470	CAT EYE SYNDROME; CES		22q11	22:15000000-25500000	
#117650	CEREBROCOSTOMANDIBULAR SYNDROME; CCMS		20p13		
#118450	ALAGILLE SYNDROME 1; ALGS1		20p12.2		
#220500	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS		16p13.3		
#605231	BARDET-BIEDL SYNDROME 6; BBS6		20p12.2		
#605259	SPINOCEREBELLAR ATAXIA 13; SCA13		19q13.33		
#300143	MENTAL RETARDATION, X-LINKED 21; MRX21		Xp21.3-p21.2		
#300166	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2		Xp11.4		
#609029	EMANUEL SYNDROME		22q11.2	22:17400000-25500000	
#609136	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH		22q13.1		
#139210	MYHRE SYNDROME; MYHRS		18q21.2		
#141750	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED		16pter-p13.3		
#145410	OPITZ GBBB SYNDROME, TYPE II; GBBB2		22q11.23		
#146390	CHROMOSOME 18p DELETION SYNDROME		18p		
#148050	KBG SYNDROME; KBGS		16q24.3		
#162200	NEUROFIBROMATOSIS, TYPE I; NF1		17q11.2		
#180849	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1		16p13.3		
#182290	SMITH-MAGENIS SYNDROME; SMS	SMITH-MAGENIS SYNDROME CHROMOSOME REGION, INCLUDED; SMCR, INCLUDED	17p11.2		
#190685	DOWN SYNDROME	DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED	21q22.3	21:41200000-46709983	
#192430	VELOCARDIOFACIAL SYNDROME; VCFS		22q11.21		
#193700	ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A		17p13.1		
#204000	LEBER CONGENITAL AMAUROSIS 1; LCA1		17p13.1		
#204200	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3		16p12.1		
#208050	ARTERIAL TORTUOSITY SYNDROME; ATORS		20q13.12		
#210720	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2		21q22.3		
#216360	COACH SYNDROME		4p15.32, 8q22.1, 16q12.2		
#600513	EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1		20q13.33		
#601088	AYME-GRIPP SYNDROME; AYGRP		16q23.2		
#601675	TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1		19q13.32		
#601808	CHROMOSOME 18q DELETION SYNDROME		18q	18:18500000-80373285	
#602473	ENCEPHALOPATHY, ETHYLMALONIC; EE		19q13.31		
#602535	MARSHALL-SMITH SYNDROME; MRSHSS		19p13.13		
#603387	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1		19p13.11		
#604004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1		22q13.33		
#604317	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2		19q13.12		
#605039	BOHRING-OPITZ SYNDROME; BOPS		20q11.21		
#226750	KOHLSCHUTTER-TONZ SYNDROME; KTZS		16p13.3		
#227650	FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA	FANCONI ANEMIA, ESTREN-DAMESHEK VARIANT, INCLUDED	16q24.3		
#229050	FOLATE MALABSORPTION, HEREDITARY		17q11.2		
#231950	GLUTATHIONURIA		22q11.23		
#235510	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1; HKLLS1		18q21.32		
#236200	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED, INCLUDED	21q22.3		
#239500	HYPERPROLINEMIA, TYPE I; HYRPRO1		22q11.21		
#245800	LAURENCE-MOON SYNDROME; LNMS		19p13.2		
#247200	MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	CHROMOSOME 17p13.3 DELETION SYNDROME, INCLUDED	17p13.3		
#248500	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA		19p13.13		
#248600	MAPLE SYRUP URINE DISEASE; MSUD	MAPLE SYRUP URINE DISEASE, CLASSIC, INCLUDED	1p21.2, 6q14.1, 19q13.2		
#248700	MARDEN-WALKER SYNDROME; MWKS		18p11.22-p11.21		
#250800	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	METHEMOGLOBINEMIA, TYPE I, INCLUDED	22q13.2		
#251255	JAWAD SYNDROME; JWDS		18q11.2		
#251270	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1		22q13.33		
#251450	DESBUQUOIS DYSPLASIA 1; DBQD1	DESBUQUOIS DYSPLASIA, KIM VARIANT, INCLUDED	17q25.3		
#252605	MUCOLIPIDOSIS III GAMMA		16p13.3		
#252650	MUCOLIPIDOSIS IV; ML4		19p13.2		
#252900	MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A		17q25.3		
#252920	MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B		17q21.2		
#256540	GALACTOSIALIDOSIS; GSL		20q13.12		
#256600	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A		22q13.1		
#256850	GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1		16q23.2		
#260565	PEHO SYNDROME; PEHO		17q12		
#264470	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY		17q25.1		
#266130	GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD		20q11.22		
#266510	PEROXISOME BIOGENESIS DISORDER 3B; PBD3B		17q12		
#269150	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME		18q12.3		
#270200	SJOGREN-LARSSON SYNDROME; SLS		17p11.2		
#271930	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI		19q13.33		
#272430	CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1		19p13.11		
#274400	THYROID DYSHORMONOGENESIS 1; TDH1		19p13.11		
#275350	TRANSCOBALAMIN II DEFICIENCY		22q12.2		
#276600	TYROSINEMIA, TYPE II; TYRSN2		16q22.2		
#277600	WEILL-MARCHESANI SYNDROME 1; WMS1		19p13.2		
#278760	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	XERODERMA PIGMENTOSUM, TYPE F/COCKAYNE SYNDROME, INCLUDED; XPF/CS, INCLUDED	16p13.12		
#280000	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME		17p11.2		
#300004	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA		Xp21.3		
#300049	PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1	HETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA, INCLUDED	Xq28		
#300055	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13		Xq28		
#300067	LISSENCEPHALY, X-LINKED, 1; LISX1	SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED; SCLH, INCLUDED	Xq23		
#300209	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2		Xp22.2		
#300210	MENTAL RETARDATION, X-LINKED 58; MRX58		Xp11.4		
#300238	MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11		Xq26.3		
#300243	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH		Xq26.3		
#300263	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD		Xp11.22		
#300271	MENTAL RETARDATION, X-LINKED 72; MRX72		Xq28		
#300322	LESCH-NYHAN SYNDROME; LNS	HPRT DEFICIENCY, NEUROLOGIC VARIANT, INCLUDED	Xq26.2-q26.3		
#300337	HYPOMELANOSIS OF ITO; HMI				
#300352	CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1		Xq28		
#300354	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC		Xq24		
#300373	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS		Xq11.2		
#300387	MENTAL RETARDATION, X-LINKED 63; MRX63		Xq23		
#300419	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED; MRXARX		Xp21.3		
#300425	AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1		Xq13.1		
#300472	CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA		Xq13.1		
#300475	DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	CONTIGUOUS ABCD1/DXS1375E DELETION SYNDROME, INCLUDED; CADDS, INCLUDED	Xq28		
#300495	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	MENTAL RETARDATION, X-LINKED, INCLUDED	Xp22.32-p22.31		
#300496	AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3		Xq28		
#300514	FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB		Xp22.2		
#300523	ALLAN-HERNDON-DUDLEY SYNDROME; AHDS		Xq13.2		
#300534	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ		Xp11.22		
#300578	CHROMOSOME Xp11.3 DELETION SYNDROME		Xp11.3	X:42500000-47600000	
#300607	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8; DEE8		Xq11.1		
#300624	FRAGILE X SYNDROME; FXS		Xq27.3		
#300653	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY		Xq21.1		
#300659	MENTAL RETARDATION, X-LINKED 93; MRX93		Xq21.1		
#300661	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	GOUT, PRPS-RELATED, INCLUDED	Xq22.3		
#300672	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2; DEE2		Xp22.13		
#300673	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS		Xq28		
#300676	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14		Xq24		
#300699	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW		Xq25		
#300749	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH		Xp11.4		
#300799	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR		Xq26.1		
#300801	CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME		Xp11.23-p11.22	X:47600000-54800000	
#300802	MENTAL RETARDATION, X-LINKED 96; MRX96		Xp11.23		
#300803	MENTAL RETARDATION, X-LINKED 97; MRX97		Xq21.1		
#300804	JOUBERT SYNDROME 10; JBTS10		Xp22.2		
#300831	CK SYNDROME		Xq28		
#300844	MENTAL RETARDATION, X-LINKED 19; MRX19		Xp22.12		
#300849	MENTAL RETARDATION, X-LINKED 41; MRX41		Xq28		
#300850	MENTAL RETARDATION, X-LINKED 90; MRX90		Xq13.1		
#300860	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN		Xq24		
#300863	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA		Xp11.23		
#300869	CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME		Xq27.3-q28	X:143000000-156040895	
#300886	MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32		Xq28		
#300894	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5		Xp11.23		
#300895	OHDO SYNDROME, X-LINKED; OHDOX		Xq13.1		
#300912	MENTAL RETARDATION, X-LINKED 98; MRX98		Xq13.3		
#300915	MICROPHTHALMIA, SYNDROMIC 13; MCOPS13		Xq28		
#300919	MENTAL RETARDATION, X-LINKED 99; MRX99		Xp11.4		
#300923	MENTAL RETARDATION, X-LINKED 100; MRX100		Xq13.1		
#300928	MENTAL RETARDATION, X-LINKED 101; MRX101		Xq22.3		
#300953	TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE; TTD5		Xq24		
#301040	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX		Xq21.1		
#301835	ARTS SYNDROME; ARTS		Xq22.3		
#301900	BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS		Xq26.2		
#302350	NANCE-HORAN SYNDROME; NHS		Xp22.2-p22.1		
#303110	CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION		Xq21	X:76800000-99100000	
#303350	MASA SYNDROME		Xq28		
#303600	COFFIN-LOWRY SYNDROME; CLS		Xp22.12		
#304100	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED		Xq28		
#304120	OTOPALATODIGITAL SYNDROME, TYPE II; OPD2		Xq28		
#304340	PETTIGREW SYNDROME; PGS		Xp22.2		
#304800	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED		Xq28		
#305000	DYSKERATOSIS CONGENITA, X-LINKED; DKCX	HOYERAAL-HREIDARSSON SYNDROME, INCLUDED; HHS, INCLUDED	Xq28		
#305400	AARSKOG-SCOTT SYNDROME; AAS	FACIOGENITAL DYSPLASIA WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER, INCLUDED	Xp11.22		
#305450	OPITZ-KAVEGGIA SYNDROME; OKS		Xq13.1		
#305600	FOCAL DERMAL HYPOPLASIA; FDH		Xp11.23		
#305620	FRONTOMETAPHYSEAL DYSPLASIA 1; FMD1		Xq28		
#307000	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS	HYDROCEPHALUS, X-LINKED, WITH CONGENITAL IDIOPATHIC INTESTINAL PSEUDOOBSTRUCTION, INCLUDED	Xq28		
#307030	GLYCEROL KINASE DEFICIENCY; GKD		Xp21.2		
#308050	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS		Xq28		
#308205	IFAP SYNDROME 1, WITH OR WITHOUT BRESHECK SYNDROME; IFAP1		Xp22.12		
#308300	INCONTINENTIA PIGMENTI; IP		Xq28		
#308350	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1		Xp21.3		
#309000	LOWE OCULOCEREBRORENAL SYNDROME; OCRL		Xq26.1		
#309400	MENKES DISEASE; MNK		Xq21.1		
#309500	RENPENNING SYNDROME 1; RENS1		Xp11.23		
#309510	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS		Xp21.3		
#309520	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUJAN-FRYNS TYPE; MRXSLF		Xq13.1		
#309541	METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE		Xq28		
#309548	MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE		Xq28		
#309549	MENTAL RETARDATION, X-LINKED 9; MRX9		Xp11.23		
#309580	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1		Xq21.1		
#309583	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR		Xp22.11		
#309585	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS		Xq12		
#309590	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST		Xp11.22		
#309800	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1		Xq28		
#309801	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1		Xp22.2		
#309900	MUCOPOLYSACCHARIDOSIS, TYPE II; MPS2		Xq28		
#310440	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX		Xq28		
#310600	NORRIE DISEASE; ND		Xp11.3		
#311200	OROFACIODIGITAL SYNDROME I; OFD1		Xp22.2		
#311250	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO		Xp11.4		
#311300	OTOPALATODIGITAL SYNDROME, TYPE I; OPD1	OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED	Xq28		
#311510	WAISMAN SYNDROME; WSMN		Xq28		
#312080	PELIZAEUS-MERZBACHER DISEASE; PMD		Xq22.2		
#312170	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	LACTIC ACIDEMIA, THIAMINE-RESPONSIVE, INCLUDED	Xp22.12		
#312750	RETT SYNDROME; RTT	RETT SYNDROME, ZAPPELLA VARIANT, INCLUDED	Xq28		
#312920	SPASTIC PARAPLEGIA 2, X-LINKED; SPG2		Xq22.2		
#605899	GLYCINE ENCEPHALOPATHY; GCE	HYPERGLYCINEMIA, TRANSIENT NEONATAL, INCLUDED; TNH, INCLUDED	3p21.31, 9p24.1, 16q23.2		
#606232	PHELAN-MCDERMID SYNDROME; PHMDS		22q13.33		
#606612	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5; MDDGB5		19q13.32		
#606854	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP		16q21		
#607341	FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2	FOCAL CORTICAL DYSPLASIA, TYPE IIA, INCLUDED; FCORD2A, INCLUDED	1p36.22, 9q34.13, 16p13.3		
#607432	LISSENCEPHALY 1; LIS1	SUBCORTICAL LAMINAR HETEROTOPIA, INCLUDED; SCLH, INCLUDED	17p13.3		
#607944	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI		19p13.2		
#608097	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM		20q13.13		
#608363	CHROMOSOME 22q11.2 DUPLICATION SYNDROME		22q11.2	22:17400000-25500000	
#608443	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3		19p13.12		
#608840	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6; MDDGB6		22q12.3		
#611560	JOUBERT SYNDROME 7; JBTS7		16q12.2		
#611584	WAARDENBURG SYNDROME, TYPE 2E; WS2E		22q13.1		
#611867	CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL		22q11.2	22:17400000-25500000	
#611881	GLYCOGEN STORAGE DISEASE XII; GSD12		16p11.2		
#612438	LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6		19p13.3		
#612736	CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2		19p13.3		
#613026	CHROMOSOME 19q13.11 DELETION SYNDROME, DISTAL		19q13.11	19:31900000-35100000	
#613153	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5		19q13.32		
#613154	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6		22q12.3		
#613159	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1		22q13.2		
#613161	BETA-UREIDOPROPIONASE DEFICIENCY; UPB1D		22q11.23		
#613180	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 8; CDCBM8		22q11.21		
#613254	TUBEROUS SCLEROSIS 2; TSC2	TSC2 ANGIOMYOLIPOMAS, RENAL, MODIFIER OF, INCLUDED	12q15, 16p13.3		
#613402	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ		19q13.33		
#613458	CHROMOSOME 16p13.3 DUPLICATION SYNDROME		16p13.3		
#613470	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY		19q13.11		
#609241	SCHINDLER DISEASE, TYPE I	ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE III, INCLUDED	22q13.2		
#609528	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME		22q11.21		
#610185	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2		17p13.3		
#610443	KOOLEN-DE VRIES SYNDROME; KDVS		17q21.31		
#610883	POTOCKI-LUPSKI SYNDROME; PTLS		17p11.2	17:16100000-22700000	
#610954	PITT-HOPKINS SYNDROME; PTHS		18q21.2		
#611087	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE		17q23.3		
#613604	CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB		16p12.2-p11.2	16:21200000-35300000	
#613680	BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS		16p13.3		
#613684	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2		22q13.2		
#613720	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7; DEE7		20q13.33		
#613804	MEIER-GORLIN SYNDROME 4; MGORS4		16q24.3		
#613950	SCHIZOPHRENIA 15; SCZD15		22q13.33		
#614019	LISSENCEPHALY 4; LIS4		16p13.11		
#614020	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14		19p13.12		
#614039	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1		16q24.3		
#614053	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3		20q13.32		
#614098	KEPPEN-LUBINSKY SYNDROME; KPLBS		21q22.13		
#614104	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7		21q22.13		
#614231	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS		18q21.1		
#614256	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10		22q12.3		
#614257	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11		20q11.23		
#614322	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12		16q23.1-q23.2		
#614526	CHROMOSOME 17q12 DUPLICATION SYNDROME		17q12	17:33500000-39800000	
#614527	CHROMOSOME 17q12 DELETION SYNDROME		17q12	17:33500000-39800000	
#614608	COFFIN-SIRIS SYNDROME 3; CSS3		22q11.23		
#614609	COFFIN-SIRIS SYNDROME 4; CSS4		19p13.2		
#614753	SOTOS SYNDROME 2; SOTOS2		19p13.13		
#614833	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP		18q22.2		
#614961	PONTOCEREBELLAR HYPOPLASIA, TYPE 8; PCH8		16q24.3		
#615084	MITOCHONDRIAL DNA DEPLETION SYNDROME 11; MTDPS11		20p11.23		
#615284	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3		22q13.33		
#615286	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36		19p13.3		
#615502	MENTAL RETARDATION, AUTOSOMAL DOMINANT 21; MRD21		16q22.1		
#615637	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41		19q13.32		
#615663	WARBURG MICRO SYNDROME 4; WARBM4		20p13		
#615777	DESBUQUOIS DYSPLASIA 2; DBQD2		16p12.3		
#615851	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E		17p13.3		
#615981	BARDET-BIEDL SYNDROME 2; BBS2		16q13		
#615990	BARDET-BIEDL SYNDROME 13; BBS13		17q22		
#616078	MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29		18q12.3		
#616723	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA		16q13		
#616734	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2		18q12.1-q12.2		
#616763	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD		19q13.2		
#616878	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN		22q11.21		
#617389	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53; DEE53		21q22.11		







